Latest Stories
Astec (NASDAQ:ASTE) Beats Expectations in Strong Q4 CY2025
Construction equipment company Astec (NASDAQ:ASTE) announced better-than-expected revenue in Q4 CY2025, with sales up 11.6% year on year to $400.6 million. Its non-GAAP profit of $1.06 per share was 27.7% above analysts’ consensus estimates.
Photronics (NASDAQ:PLAB) Posts Better-Than-Expected Sales In Q4, Stock Soars
Semiconductor photomask manufacturer Photronics (NASDAQ:PLAB) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 6.1% year on year to $225.1 million. The company expects next quarter’s revenue to be around $216 million, close to analysts’ estimates. Its non-GAAP profit of $0.61 per share was 15.1% above analysts’ consensus estimates.
Steven Madden’s (NASDAQ:SHOO) Q4 CY2025 Earnings Results: Revenue In Line With Expectations
Shoe and apparel company Steven Madden (NASDAQ:SHOO) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 29.4% year on year to $753.7 million. Its non-GAAP profit of $0.48 per share was in line with analysts’ consensus estimates.
Dine Brands (NYSE:DIN) Misses Q4 CY2025 Sales Expectations
Casual restaurant chain Dine Brands (NYSE:DIN) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 6.3% year on year to $217.6 million. Its non-GAAP profit of $1.46 per share was 38.2% above analysts’ consensus estimates.
Hayward (NYSE:HAYW) Surprises With Q4 CY2025 Sales
Pool equipment and automation systems manufacturer Hayward Holdings (NYSE:HAYW) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 6.8% year on year to $349.4 million. Its non-GAAP profit of $0.29 per share was in line with analysts’ consensus estimates.
Bloomin' Brands (NASDAQ:BLMN) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings
Restaurant company Bloomin’ Brands (NASDAQ:BLMN) missed Wall Street’s revenue expectations in Q4 CY2025, with sales flat year on year at $975.2 million. Its non-GAAP profit of $0.25 per share was in line with analysts’ consensus estimates.
United Therapeutics (NASDAQ:UTHR) Misses Q4 CY2025 Revenue Estimates
Biotechnology company United Therapeutics (NASDAQ:UTHR) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 7.4% year on year to $790.2 million. Its GAAP profit of $7.70 per share was 14% above analysts’ consensus estimates.
CLEAR Secure (NYSE:YOU) Exceeds Q4 CY2025 Expectations, Stock Soars
Identity verification company CLEAR Secure (NYSE:YOU) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 16.7% year on year to $240.8 million. Its GAAP profit of $0.31 per share was in line with analysts’ consensus estimates.
LifeStance Health Group (NASDAQ:LFST) Posts Better-Than-Expected Sales In Q4 CY2025, Stock Jumps 12.7%
Behavioral health company LifeStance Health (NASDAQ:LFST) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 17.4% year on year to $382.2 million. Guidance for next quarter’s revenue was optimistic at $390 million at the midpoint, 2.4% above analysts’ estimates. Its GAAP profit of $0.03 per share was significantly above analysts’ consensus estimates.
Owens Corning (NYSE:OC) Misses Q4 CY2025 Revenue Estimates
Building and construction materials manufacturer Owens Corning (NYSE:OC) fell short of the market’s revenue expectations in Q4 CY2025, with sales falling 24.6% year on year to $2.14 billion. Next quarter’s revenue guidance of $2.15 billion underwhelmed, coming in 3.4% below analysts’ estimates. Its non-GAAP profit of $1.10 per share was 18.8% below analysts’ consensus estimates.